Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Including androgens in hormone therapy may lower breast cancer risk.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Removing both ovaries treated the woman's excess male hormone symptoms.

New diabetes tech and therapies improve care for endocrine disorders.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Hair loss is a common side effect of hormone treatments for cancer.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

A 70-year-old woman with a malignant adrenal tumor improved after surgery and radiotherapy.